Accepted at 11:02 a.m. May, 27, 2025 by zarathustra
Author: gizemkeles
Co-authors: zarathustra
Related Note: 1485037278052 1
Rationale for change

Changed one-by-one for only the C1 cloze.

Text Text
One by one One by one
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
#AK_Step1_v12::#Textbooks::#Golan_Pharmacology::11_Adrenergic_Pharmacology #AK_Step2_v12::#Bootcamp::Psychiatry::01_Diagnosis_and_Management::02_Psychotic_Disorders::07_Neuroleptic_Malignant_Syndrome_and_Serotonin_Syndrome #AK_Step2_v12::#COMBANK::54010 #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::03_Movement_Disorders::03_Myoclonus #AK_Step1_v12::#UWorld::Step::2088 #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::06_Drug_reactions-gastrointestinal #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#B&B::19_Psych::04_Pharm::01_Antidepressants #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step1_v12::#B&B::19_Psych::03_Substance_Use_Disorders::04_Other_Drugs #AK_Step2_v12::#NBME::Form13::Section_1 #AK_Other::Card_Features::Clinical_Sign::GIF #AK_Step2_v12::#UWorld::Step::12305 #AK_Step3_v12::#UWorld::5711 #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step1_v12::#B&B::16_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters::Extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#NBME #AK_Step2_v12::#UWorld::Step::12146 #PANCE::BEHAVIORAL::anxiety_disorders #AK_Step2_v12::#AMBOSS::t70Xnh #AK_Step1_v12::#AMBOSS::CZaqdQ #PANCE::EOR::Family_med #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #PANCE::EOR::PEDS #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::17_Serotonin_Syndrome #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#OME::04_Psychiatry::11_Catatonia #AK_Step2_v12::#DirtyMedicine::12_Psychiatry::02_Serotonin_Syndrome_vs._Neuroleptic_Malignant_Syndrome #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step2_v12::#UWorld::COMLEX::102072 #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#UWorld::Step::8327 #AK_Step1_v12::#AMBOSS::jSa_zP #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::16_Psychiatric_Emergencies #AK_Step2_v12::#AMBOSS::CZaqdQ #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step2_v12::#UWorld::#UWSA2 #AK_Step1_v12::#NBME::32 #AK_Step1_v12::#OME::Clinical::Psychiatry::Personality_and_Psychosis::Catatonia #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #AK_Step2_v12::#AMBOSS::jSa_zP #AK_Step1_v12::#Textbooks::#Cecil::90_Fever_and_Febrile_Syndromes #AK_Step2_v12::#Subjects::Psychiatry::05_Mood_Disorders::Major_Depressive_Disorder::Management::*Serotonin_Syndrome #PANCE::EOR::PSYCH #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#UWorld::COMLEX::25379 #AK_Step2_v12::#UWorld::COMLEX::104411 #AK_Step2_v12::Original_decks::Dorian::psych::uw #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step2_v12::#UWorld::Step::19779 #AK_Step2_v12::#CMS::Psychiatry::Form_03 #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::40_Psychiatric_emergencies::*Serotonin_Syndrome::Symptoms #AK_Step2_v12::#UWorld::Step::20355 #AK_Step1_v12::#UWorld::COMLEX::25197 #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::01_SSRIs #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::01_Antidepressants #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::01_Serotonin_Syndrome